Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01
-
Shares outstanding
-
315,976,000
-
Number of holders
-
154
-
Total 13F shares, excl. options
-
116,115,404
-
Shares change
-
+7,732,113
-
Total reported value, excl. options
-
$1,571,109,084
-
Value change
-
+$90,619,744
-
Put/Call ratio
-
0%
-
Number of buys
-
62
-
Number of sells
-
86
-
Price
-
$13.53
Institutional Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q4 2018
As of 31 Dec 2018 Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) had 194 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 116,115,404 shares of stock of the company.
Largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, Fosun International Ltd, WELLINGTON MANAGEMENT GROUP LLP, Vanguard Group Inc, FMR LLC, BlackRock Inc., TPG Group Holdings (SBS) Advisors, Inc., FRONTIER CAPITAL MANAGEMENT CO LLC, JANUS HENDERSON GROUP PLC, and Viking Global Investors LP.
This table shows 194 institutional shareholders of the security as of 31 Dec 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.